Last Updated on July 28, 2021 by HepFree NYC
Related Articles
-
Article | Excluding People Who Use Drugs or Alcohol from Hep C Treatment – Is This Fair, Given the Available Data?
We will examine restrictions to assess whether they meet evidenced-based medical and public health criteria, and whether they satisfy the principle of justice.
-
Job | Check Hep C Patient Navigator
Check Hep C Patient Navigator BOOM!Health Primary Duties & Responsibilities include, but are not limited to: Job Summary The Patient Navigator provides quality and comprehensive HCV testing and Health Education, Risk Reduction and HCV prevention education services targeting P...
-
Support Funding for Viral Hepatitis–Urge Your House Representative
We have the tools to prevent the major causes of viral hepatitis and liver cancer – a hepatitis B vaccine and effective treatments that reduce disease progression, new diagnostics for HCV and treatments that increase cure rates over 90%, and even more medical advances in the re...
-
Dear Colleague Letter | Hep B & C Screening & Treatment Guidance 2020 (NYC Health Dept)
In March 2020, the United States Preventive Services Task Force recommended one-time screening for hepatitis C in people aged 18-79. Simplified treatment guidance has been developed for hepatitis B and C.
-
NYS ADAP Includes New Hep C Meds on Formulary
NYS ADAP will be offering access to new Hep C meds, including Zepatier, Viekira pak, Viekira XR, and Daklinza.
-
Funding | RFA for Funding for FQHC’s to Address Opioid Crisis NY (Due March 7, 2019)
OASAs will issue up to 10 awards of up to $350,000 each to Federally Qualified Health Centers (FQHCs) to expand or establish opioid disorder services, including medication assisted treatment (MAT)
-
CVS Caremark: Funding for Organizations Serving the Uninsured
Applicants must be nonprofit organizations in states with CVS/pharmacy stores. Qualifying organizations are eligible for grants of up to $5,000 each.
-
New CDC estimates reveal declines in Hep C treatment 2015 – 2020
New CDC estimates reveal declines in hepatitis C treatment 2015 – 2020
